Filing Details
- Accession Number:
- 0001702626-19-000006
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-06-25 12:17:18
- Reporting Period:
- 2019-06-21
- Accepted Time:
- 2019-06-25 12:17:18
- Original Submission Date:
- 2019-06-21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 946644 | Hemispherx Biopharma Inc | HEB | Biological Products, (No Disgnostic Substances) (2836) | 520845822 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1450324 | K. Thomas Equels | 2117 Sw Highway 484 Ocala FL 34473 | Exec. Vice Chairman/Ceo/Pres. | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-06-21 | 29,404 | $4.03 | 60,409 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The amount of securities previously owned is being adjusted due to the 44 to 1 reverse stock split which occurred on June 11, 2019.
Billionaire Hedge Funds
